Besancon University Hospital Center

At Besancon University Hospital Center, research in cardiovascular diseases focuses on preventing serious events such as ischemic stroke and atherosclerotic cardiovascular disease. The trials are designed to assess whether new approaches can better reduce future heart and brain complications in people at elevated risk.

• Prevention of major adverse cardiovascular events in high-risk patients
• Reducing recurrent ischemic stroke after a recent stroke or high-risk transient ischemic attack
• Evaluating new treatments for primary prevention of ASCVD

These studies aim to improve long-term protection against clot-related vascular events and support better preventive care in everyday practice.

The oncology research program at the Service de d'Oncologie-Radiothérapie includes trials in acute myeloid leukemia and prostate cancer. The main goal is to find more effective ways to deepen remission, strengthen treatment response, and improve outcomes for patients with aggressive or high-risk cancers.

• Improving remission rates in acute myeloid leukemia
• Testing better treatment strategies for high-risk localized or locally advanced prostate cancer
• Supporting more precise cancer care through treatment-response evaluation

These studies reflect a strong focus on both blood cancers and solid tumors, with an emphasis on better disease control and longer-lasting benefit.